CD40 and neoplasm: In addition to TAM depletion, skewing TAMs toward an immunostimulatory M1 phenotype using CD40 mAb may even hold more clinical potential, as CD40 mAb-activated macrophages in pancreatic cancer infiltrate the tumor and facilitate tumor stroma depletion.162